AxoGen (AXGN)
(Delayed Data from NSDQ)
$13.16 USD
-0.08 (-0.60%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $13.13 -0.03 (-0.23%) 7:10 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for AxoGen, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 37 | 55 | 90 | 111 | 103 |
Receivables | 25 | 22 | 18 | 18 | 17 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 23 | 19 | 17 | 13 | 14 |
Other Current Assets | 3 | 2 | 2 | 4 | 2 |
Total Current Assets | 88 | 98 | 127 | 145 | 135 |
Net Property & Equipment | 89 | 79 | 63 | 38 | 15 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 5 | 4 | 3 | 2 | 2 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 197 | 195 | 208 | 201 | 155 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 29 | 22 | 22 | 22 | 19 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 2 |
Current Portion Capital Leases | 2 | 1 | 2 | 1 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 30 | 24 | 24 | 23 | 21 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 47 | 46 | 45 | 32 | 2 |
Non-Current Capital Leases | 21 | 20 | 21 | 21 | 0 |
Other Non-Current Liabilities | 3 | 5 | 6 | 3 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 101 | 94 | 95 | 78 | 22 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 377 | 360 | 343 | 326 | 312 |
Retained Earnings | -281 | -260 | -231 | -204 | -180 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 96 | 101 | 113 | 123 | 132 |
Total Liabilities & Shareholder's Equity | 197 | 195 | 208 | 201 | 155 |
Total Common Equity | 96 | 101 | 113 | 123 | 132 |
Shares Outstanding | 43.00 | 42.20 | 41.50 | 40.60 | 39.40 |
Book Value Per Share | 2.22 | 2.39 | 2.71 | 3.03 | 3.35 |
Fiscal Year End for AxoGen, Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 27 | 24 | 37 | 39 |
Receivables | NA | 25 | 24 | 25 | 23 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 28 | 28 | 23 | 23 |
Other Current Assets | NA | 2 | 3 | 3 | 3 |
Total Current Assets | NA | 82 | 79 | 88 | 87 |
Net Property & Equipment | NA | 87 | 88 | 89 | 89 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 5 | 5 | 5 | 4 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 189 | 187 | 197 | 195 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 22 | 21 | 29 | 26 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 2 | 2 | 2 | 1 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 23 | 23 | 30 | 27 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 47 | 47 | 47 | 46 |
Non-Current Capital Leases | NA | 20 | 21 | 21 | 20 |
Other Non-Current Liabilities | NA | 3 | 3 | 4 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 93 | 93 | 101 | 97 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 385 | 381 | 377 | 375 |
Retained Earnings | NA | -290 | -288 | -281 | -277 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 96 | 93 | 96 | 98 |
Total Liabilities & Shareholder's Equity | NA | 189 | 187 | 197 | 195 |
Total Common Equity | 0 | 96 | 93 | 96 | 98 |
Shares Outstanding | 43.80 | 43.70 | 43.70 | 43.00 | 42.90 |
Book Value Per Share | 0.00 | 2.19 | 2.13 | 2.22 | 2.28 |